Shares of Outlook Therapeutics posted wide swings as the Food and Drug Administration approved the company's Lytenava for treatment of neovascular age-related macular degeneration.

NextEra Energy recorded a big jump in profit for the second quarter from climbing revenue and a decline in costs. The clean-energy company posted a profit of $3.14 billion, or $1.50 a share, up from ...

Question: “I’m 63 years old and I’m wondering how I should maximize a $500,000 inheritance for imminent retirement. How do I ...

American Express customers just registered their highest spending growth in three years — and the company is seeing particularly strong interest in its Platinum cards.

Correction: An earlier version of this report said the Dow finished lower on Friday. It has been corrected. U.S. stocks finished mixed on Friday, with the S&P 500 and Dow finishing lower, and the ...

A group including the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) on Friday announced that the majority of rare earth elements retrieved from sediment collected from the seabed off ...

The USDA on Friday published its biannual Cattle Inventories Report, as well as its monthly Cattle on Feed Report, which both showed more cattle in the U.S. The amount of cattle o ...

If the mountains are calling you, let history whisper its stories through these seven cultural experiences to ...

Bluerock Acquisition Corp. II has filed for an initial public offering. The special-purpose acquisition company said it will sell 15 million units at $10 apiece, according to a filing with the ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 slipped 1.19% to 1,152.60 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index ...

The Japan Aerospace Exploration Agency (JAXA) on Thursday conducted a ground combustion test of a second-stage engine for the Epsilon S small solid-fuel rocket that it is currently developing.

Follow all the latest U.S. market action for Friday here.